Vaccine Manufacturer Gives Positive Outlook For Production

South African vaccine manufacturer Biovac Institute has announced that it is increasing production capacity to 35mn doses by 2013. The drugmaker's main market will be the rest of Africa, promoting continental expansion while also reducing the burden of expensive foreign imports for many small states which have little or no domestic medicine production.

To read the full article, please choose one of the following options: